vs

Side-by-side financial comparison of Soluna Holdings, Inc (SLNH) and STRATA Skin Sciences, Inc. (SSKN). Click either name above to swap in a different company.

STRATA Skin Sciences, Inc. is the larger business by last-quarter revenue ($9.3M vs $8.4M, roughly 1.1× Soluna Holdings, Inc). STRATA Skin Sciences, Inc. runs the higher net margin — 0.6% vs -284.7%, a 285.3% gap on every dollar of revenue. On growth, Soluna Holdings, Inc posted the faster year-over-year revenue change (11.8% vs -3.0%). STRATA Skin Sciences, Inc. produced more free cash flow last quarter ($-551.0K vs $-6.8M). Over the past eight quarters, STRATA Skin Sciences, Inc.'s revenue compounded faster (17.3% CAGR vs -8.8%).

Strata Skin Sciences is an American medical device company focused on the design, development and commercialization of non-invasive tools to provide additional information to dermatologists during melanoma skin examinations.

SLNH vs SSKN — Head-to-Head

Bigger by revenue
SSKN
SSKN
1.1× larger
SSKN
$9.3M
$8.4M
SLNH
Growing faster (revenue YoY)
SLNH
SLNH
+14.8% gap
SLNH
11.8%
-3.0%
SSKN
Higher net margin
SSKN
SSKN
285.3% more per $
SSKN
0.6%
-284.7%
SLNH
More free cash flow
SSKN
SSKN
$6.3M more FCF
SSKN
$-551.0K
$-6.8M
SLNH
Faster 2-yr revenue CAGR
SSKN
SSKN
Annualised
SSKN
17.3%
-8.8%
SLNH

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
SLNH
SLNH
SSKN
SSKN
Revenue
$8.4M
$9.3M
Net Profit
$-24.0M
$58.0K
Gross Margin
9.5%
61.8%
Operating Margin
-92.5%
5.3%
Net Margin
-284.7%
0.6%
Revenue YoY
11.8%
-3.0%
Net Profit YoY
-233.2%
101.3%
EPS (diluted)
$-1.14
$0.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SLNH
SLNH
SSKN
SSKN
Q4 25
$9.3M
Q3 25
$8.4M
$6.9M
Q2 25
$6.2M
$7.7M
Q1 25
$5.9M
$6.8M
Q4 24
$8.3M
$9.6M
Q3 24
$7.5M
$8.8M
Q2 24
$9.7M
$8.4M
Q1 24
$12.5M
$6.8M
Net Profit
SLNH
SLNH
SSKN
SSKN
Q4 25
$58.0K
Q3 25
$-24.0M
$-1.6M
Q2 25
$-7.4M
$-2.6M
Q1 25
$-7.6M
$-2.1M
Q4 24
$-40.0M
$-4.6M
Q3 24
$-7.2M
$-2.1M
Q2 24
$-10.9M
$-91.0K
Q1 24
$-5.3M
$-3.4M
Gross Margin
SLNH
SLNH
SSKN
SSKN
Q4 25
61.8%
Q3 25
9.5%
60.4%
Q2 25
6.3%
56.2%
Q1 25
5.7%
53.5%
Q4 24
-360.8%
61.4%
Q3 24
-39.1%
60.1%
Q2 24
34.6%
59.0%
Q1 24
45.4%
45.6%
Operating Margin
SLNH
SLNH
SSKN
SSKN
Q4 25
5.3%
Q3 25
-92.5%
-16.9%
Q2 25
-107.6%
-30.1%
Q1 25
-120.9%
-25.0%
Q4 24
-426.0%
-44.7%
Q3 24
-119.8%
-18.2%
Q2 24
-38.0%
-5.7%
Q1 24
3.2%
-42.7%
Net Margin
SLNH
SLNH
SSKN
SSKN
Q4 25
0.6%
Q3 25
-284.7%
-23.4%
Q2 25
-119.9%
-33.6%
Q1 25
-127.3%
-31.2%
Q4 24
-483.8%
-47.6%
Q3 24
-95.5%
-23.6%
Q2 24
-112.4%
-1.1%
Q1 24
-41.9%
-49.8%
EPS (diluted)
SLNH
SLNH
SSKN
SSKN
Q4 25
$0.14
Q3 25
$-1.14
$-0.36
Q2 25
$-0.93
$-0.62
Q1 25
$-1.21
$-0.51
Q4 24
$-7.14
$-2.01
Q3 24
$-1.56
$-0.51
Q2 24
$-3.62
$-0.03
Q1 24
$-2.62
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SLNH
SLNH
SSKN
SSKN
Cash + ST InvestmentsLiquidity on hand
$7.9M
Total DebtLower is stronger
$13.3M
$15.3M
Stockholders' EquityBook value
$14.5M
$2.9M
Total Assets
$152.0M
$30.5M
Debt / EquityLower = less leverage
0.92×
5.28×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SLNH
SLNH
SSKN
SSKN
Q4 25
$7.9M
Q3 25
$7.1M
Q2 25
$6.0M
Q1 25
$6.5M
Q4 24
$7.3M
Q3 24
$7.1M
Q2 24
$5.5M
Q1 24
$5.2M
Total Debt
SLNH
SLNH
SSKN
SSKN
Q4 25
$15.3M
Q3 25
$13.3M
$15.3M
Q2 25
$10.0M
$15.0M
Q1 25
$10.2M
$15.0M
Q4 24
$7.1M
$15.0M
Q3 24
$8.1M
$15.0M
Q2 24
$9.0M
$15.0M
Q1 24
$15.0M
Stockholders' Equity
SLNH
SLNH
SSKN
SSKN
Q4 25
$2.9M
Q3 25
$14.5M
$1.3M
Q2 25
$-19.5M
$532.0K
Q1 25
$-16.1M
$3.0M
Q4 24
$-12.5M
$5.0M
Q3 24
$20.9M
$9.4M
Q2 24
$24.4M
$9.5M
Q1 24
$21.5M
$9.4M
Total Assets
SLNH
SLNH
SSKN
SSKN
Q4 25
$30.5M
Q3 25
$152.0M
$30.7M
Q2 25
$92.0M
$29.5M
Q1 25
$90.0M
$33.0M
Q4 24
$88.0M
$34.9M
Q3 24
$97.3M
$39.4M
Q2 24
$98.7M
$38.8M
Q1 24
$90.6M
$39.2M
Debt / Equity
SLNH
SLNH
SSKN
SSKN
Q4 25
5.28×
Q3 25
0.92×
11.65×
Q2 25
28.20×
Q1 25
5.04×
Q4 24
3.02×
Q3 24
0.39×
1.60×
Q2 24
0.37×
1.58×
Q1 24
1.59×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SLNH
SLNH
SSKN
SSKN
Operating Cash FlowLast quarter
$-2.2M
$-239.0K
Free Cash FlowOCF − Capex
$-6.8M
$-551.0K
FCF MarginFCF / Revenue
-81.4%
-5.9%
Capex IntensityCapex / Revenue
55.2%
3.4%
Cash ConversionOCF / Net Profit
-4.12×
TTM Free Cash FlowTrailing 4 quarters
$-34.4M
$-4.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SLNH
SLNH
SSKN
SSKN
Q4 25
$-239.0K
Q3 25
$-2.2M
$-64.0K
Q2 25
$-1.1M
$-1.9M
Q1 25
$-177.0K
$-550.0K
Q4 24
$-5.1M
$703.0K
Q3 24
$61.0K
$-302.0K
Q2 24
$-7.3M
$591.0K
Q1 24
$3.9M
$-804.0K
Free Cash Flow
SLNH
SLNH
SSKN
SSKN
Q4 25
$-551.0K
Q3 25
$-6.8M
$-1.1M
Q2 25
$-9.7M
$-2.0M
Q1 25
$-4.0M
$-749.0K
Q4 24
$-13.9M
$199.0K
Q3 24
$-3.4M
$-364.0K
Q2 24
$-7.6M
$246.0K
Q1 24
$3.3M
$-1.5M
FCF Margin
SLNH
SLNH
SSKN
SSKN
Q4 25
-5.9%
Q3 25
-81.4%
-15.6%
Q2 25
-156.8%
-26.1%
Q1 25
-67.1%
-11.0%
Q4 24
-168.3%
2.1%
Q3 24
-44.8%
-4.1%
Q2 24
-78.2%
2.9%
Q1 24
26.5%
-22.6%
Capex Intensity
SLNH
SLNH
SSKN
SSKN
Q4 25
3.4%
Q3 25
55.2%
14.7%
Q2 25
139.0%
0.8%
Q1 25
64.2%
2.9%
Q4 24
107.0%
5.3%
Q3 24
45.6%
0.7%
Q2 24
2.5%
4.1%
Q1 24
4.2%
10.7%
Cash Conversion
SLNH
SLNH
SSKN
SSKN
Q4 25
-4.12×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

SLNH
SLNH

Data Hosting Revenue$5.3M62%
Cryptocurrency Mining Revenue$2.8M33%
Other$389.0K5%

SSKN
SSKN

Dermatology Recurring Procedures$6.1M65%
Dermatology Procedures Equipment$3.2M35%

Related Comparisons